Clinical Trial Update: The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluates Endostar in combination with taxane-based regimens for HER-2-negative metastatic breast cancer, focusing on efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Angiogenesis, Breast Cancer | Phase 3 | Status: UNKNOWN